(Q24244812)

1

0 references

Mauricio Silva de Lima

2

0 references

Phillipa PJ Hay

3

0 references

Josué Bacaltchuk

4

0 references

Ulrike US Schmidt

Cochrane Database of Systematic Reviews

5

0 references

publication date

25 January 2006

0 references

published in

0 references

cites work

Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Randomized controlled trial of a treatment for anorexia and bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Activity measures in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Efficacy of citalopram in anorexia nervosa: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Sertraline in underweight binge eating/purging-type eating disorders: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Citalopram in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

No effect of adjunctive fluoxetine on eating behavior or weight phobia during the inpatient treatment of anorexia nervosa: an historical case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

One-month prevalence of depression and other DSM-IV disorders among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The long QT syndrome: ion channel diseases of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Report of the National Institutes of Health workshop on overcoming barriers to treatment research in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Childhood obsessive-compulsive personality traits in adult women with eating disorders: defining a broader eating disorder phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Psychotropic drugs in the treatment of obesity: what promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Plasma tryptophan during weight restoration in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Low discharge weight and outcome in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Psychiatric comorbidity in patients with eating disorders1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Twin studies of eating disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Early-onset anorexia nervosa: is there evidence of limbic system imbalance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The aetiology of eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A neurodevelopmental model for anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Linkage analysis of anorexia nervosa incorporating behavioral covariates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Evidence-based treatment of anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Drugs that cause weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Childhood-onset anorexia nervosa: towards identifying a biological substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Toward a neurobiology of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The treatment of anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Eating disorders and depression: is there a serotonin connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A longitudinal magnetic resonance imaging study of brain changes in adolescents with anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

New directions in treatment research of anorexia and bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Anxiolytic effects of acute tryptophan depletion in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A preliminary population-based twin study of self-reported eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Functional neuroimaging in early-onset anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Depression, antidepressants and suicidality: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Standardized mortality in eating disorders--a quantitative summary of previously published and new evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Secular trends in the incidence of anorexia nervosa: integrative review of population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Central and peripheral noradrenalin regulation in eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The outcome of anorexia nervosa in the 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Risk and maintenance factors for eating pathology: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Mortality in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Selective serotonin re-uptake inhibitors in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Anorexia nervosa and major depression: shared genetic and environmental risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

Abnormalities in CNS Monoamine Metabolism in Anorexia Nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Pharmacological Treatment of Eating Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

The use of citalopram in an integrated approach to the treatment of eating disorders: an open study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

1 reference

7 January 2021

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Selective serotonin reuptake inhibitors in anorexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Cyproheptadine for anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Brain serotonin and eating behavior

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Altered Dopamine Activity after Recovery from Restricting-Type Anorexia Nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Comparison of bulimic and non-bulimic anorexia nervosa patients during treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Moderate dieting causes 5-HT2C receptor supersensitivity.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: four-year follow-up study of 41 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Deriving behavioural phenotypes in an international, multi-centre study of eating disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Hunger, eating, and ill health

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

A double-blind controlled trial of lithium carbonate primary anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

An experimental analysis of the interaction of chemotherapy and behavior therapy in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Genetics and anorexia nervosa: a review of candidate genes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Amitriptyline therapy in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Treatment of an anorexia nervosa patient with fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Does fluoxetine augment the inpatient treatment of anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021

Clinical assessment of anorexia nervosa. The Morgan-Russell outcome assessment schedule

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004365.PUB2

7 January 2021